Pediatrix Medical Group, Inc. MD
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.95B | 1.93B | 1.91B | 1.92B | 1.94B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.95B | 1.93B | 1.91B | 1.92B | 1.94B |
| Cost of Revenue | 1.44B | 1.43B | 1.42B | 1.43B | 1.47B |
| Gross Profit | 511.77M | 504.03M | 493.70M | 496.25M | 472.72M |
| SG&A Expenses | 248.03M | 242.45M | 240.79M | 238.66M | 235.99M |
| Depreciation & Amortization | 23.08M | 22.61M | 21.83M | 23.07M | 23.77M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.71B | 1.69B | 1.68B | 1.69B | 1.73B |
| Operating Income | 240.65M | 238.96M | 231.09M | 234.51M | 212.95M |
| Income Before Tax | 226.22M | 227.19M | 216.43M | 204.17M | 141.62M |
| Income Tax Expenses | 51.41M | 52.96M | 51.04M | 41.98M | 31.70M |
| Earnings from Continuing Operations | 174.81 | 174.22 | 165.39 | 162.19 | 109.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 174.81M | 174.22M | 165.39M | 162.19M | 109.92M |
| EBIT | 240.65M | 238.96M | 231.09M | 234.51M | 212.95M |
| EBITDA | 263.74M | 261.57M | 252.91M | 257.58M | 236.73M |
| EPS Basic | 2.11 | 2.08 | 1.96 | 1.91 | 1.30 |
| Normalized Basic EPS | 1.75 | 1.69 | 1.61 | 1.61 | 1.40 |
| EPS Diluted | 2.09 | 2.06 | 1.94 | 1.90 | 1.29 |
| Normalized Diluted EPS | 1.72 | 1.67 | 1.60 | 1.60 | 1.39 |
| Average Basic Shares Outstanding | 329.35M | 334.70M | 338.26M | 339.00M | 338.28M |
| Average Diluted Shares Outstanding | 334.52M | 338.63M | 340.99M | 341.73M | 340.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |